Amgen Inc. Company Information

Amgen Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Amgen Inc.
  • Ticker: AMG
  • Exchange: DB
  • Founded: 1980
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$141.575b
  • Listing Market Cap: US$135.686b
  • Shares Outstanding: 537.53m
  • Website: https://www.amgen.com

Number of Employees


Location

  • Amgen Inc.
  • One Amgen Center Drive
  • Thousand Oaks
  • California
  • 91320-1799
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AMGNNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDJun 1983
AMGN *BMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNJun 1983
000907582BRSE (Berne Stock Exchange)YesCommon StockCHCHFJun 1983
AMGXTRA (XETRA Trading Platform)YesCommon StockDEEURJun 1983
AMGDB (Deutsche Boerse AG)YesCommon StockDEEURJun 1983
AMGNSNSE (Santiago Stock Exchange)YesCommon StockCLUSDJun 1983
0R0TLSE (London Stock Exchange)YesCommon StockGBUSDJun 1983
4AMGNETLX (Eurotlx)YesCommon StockITEURJun 1983
AMGNWBAG (Wiener Boerse AG)YesCommon StockATEURJun 1983
AMGNCLSNSE (Santiago Stock Exchange)YesCommon StockCLCLPJun 1983
AMGDBATS-CHIXE (BATS 'Chi-X Europe')YesCommon StockGBEURJun 1983
AMGNBVL (Bolsa de Valores de Lima)YesCommon StockPEUSDJun 1983
AMGNBASE (Buenos Aires Stock Exchange)CEDEAR EACH 30 REP 1ARARSSep 2000
AMGNDBASE (Buenos Aires Stock Exchange)CEDEAR EACH 30 REP 1ARUSDSep 2000
AMGN34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH 28 REP 1 COMBRBRLAug 2012

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/12/22 06:01
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 06:01
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Amgen Inc. is covered by 66 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Brian SkorneyBaird
Ishan MajumdarBaptista Research